Please do not adjust margins
New Journal of Chemistry
Page 7 of 9
DOI: 10.1039/C7NJ01698K
Journal Name
ARTICLE
DMSO-d6): δ= 9.01 (s, 1H, HAr), 8.28-8.26 (overlapped peaks, 2H, HAr), 8.05-
8.01 (overlapped peaks, 6H, HAr), 7.67-7.63 (overlapped peaks, 4H, HAr) ppm.
13C NMR (125 MHz, DMSO-d6): δ=166.8; 165.3; 161.6; 144.7; 131.2; 130.3;
130.1; 129.4; 128.4; 127.8; 125.6; 124.4; 124.3; 122.5; 116.4. HRMS (APCI, +,
Orbitrap) m/z: calc. for C23H15N2O3 [M+H]+367.1077; found 367.1078.
Conclusions
In conclusion, new 1,3,4-oxadiazole-based compounds bearing
p-tolyl, naphthyl, anthracenyl and pyrenyl moieties were
efficiently synthesized by oxidative cyclisation of N-
acylhydrazones. These compounds were characterised for
their electronic and optical properties and the pyrenyl and
naphthyl substituted derivatives were found to display high
quantum yields (0.33 and 0.48, respectively) and large Stokes
4-(5-(3,8-dihydropyren-1-yl)-1,3,4-oxadiazol-2-yl)benzoic
acid
5d.
Orange solid. Yield 70 % (69 mg). m.p.>312°C. Rf=0.36 (silica, EtOAc). 1H NMR
(500 MHz, DMSO-d6): δ= 13.38 (s, 1H, COOH), 9.49 (d, 1H, 3J=9.3 Hz HAr), 8.83
(d, 1H, 3J=8.1 Hz, HAr ), 8.50-8.48 (overlapped peaks, 2H, HAr), 8.46-8.43
(overlapped peaks, 2H, HAr), 8.38-8.29 (overlapped peaks, 4H, HAr), 8.20-8.17
(overlapped peaks, 3H, HAr) ppm. 13C NMR (125 MHz, DMSO-d6): δ=166.5; shifts (124 nm and 91 nm, respectively). In addition,
164.9; 163.1; 133.5; 133.2; 130.6; 130.2; 129.9; 129.8; 129.6; 128.5; 127.1;
127.0; 126.93; 126.92; 126.90; 126.8; 126.5; 125.1; 124.4; 123.9; 123.3;
116.0. HRMS (APCI, +, Orbitrap) m/z: calc. for C25H15N2O3 [M+H]+391.1077;
found 391.1081.
profluorescent probes obtained in conjunction with stable free
radical TEMPO were further prepared and characterised by
EPR, cyclic voltammetry and XRD (for the pyrenyl-derived
nitroxide). The fluorescence of these probes could be turned
on by reaction with a reducing agent. In addition, we assessed
the usefulness of the synthesized compounds for detection of
sodium ascorbate in the low micromolar range. Our results
indicate that fine tuning of the structure could bring an
improvement of the profluorescent nitroxides behaviour in
order to enhance their properties and extend scope.
General experimental procedure for the synthesis of profluorescent
nitroxides 1a-d. The corresponding 1,3,4-oxadiazole (1 eq.) was dissolved in
dichloromethane (2-5 mL). To this solution were sequentially added PyBop
(1.1 eq.), DIPEA (3 eq.) and 4-amino-TEMPO (0.9 eq.). The reaction mixture
was allowed to stir at room temperature for 12 hours and then the solvent
was evaporated in vacuo. The residue was diluted with water and extracted
with ethyl acetate (3 x 20 mL). The organic layer was washed with saturated
solution of sodium bicarbonate (3 x 5 mL), brine and dried over anhydrous
magnesium sulphate. Purification of each product was performed by column
chromatography. The NMR spectra were performed on the reduced
compounds with phenylhydrazine. The mass spectra were performed on
reduced solutions of the samples using trifluoroacetic acid.
Acknowledgements
This work was supported by a grant of the Romanian National
Authority for Scientific Research and Innovation, CNCS-
UEFISCDI, project number PN-II-RU-TE-2014-4-0808. We thank
Dr. Gabriela Ionita and Dr. Iulia Matei for EPR measurements.
A.D. acknowledges Babes-Bolyai University for financial
N-(1-oxy-2,2,6,6-tetramethylpiperidin-4-yl)-4-(5-(p-tolyl)-1,3,4-
oxadiazol-2-yl)benzamide 1a. White solid. Yield 85% (67 mg). m.p. 174-
177°C. Rf=0.4 (silica, EtOAc). 1H NMR reduced with PhNHNH2 (500 MHz,
3
CDCl3): δ= 8.20 (d, 2H, J=8.4 Hz, HAr), 8.03 (d, 2H, 3J=8.3 Hz, HAr), 7.94 (d, 2H,
3J=8.4 Hz, HAr), 7.34 (d, 2H, 3J=8.3 Hz, HAr), 4.57-4.54 (m, 1H, CHTEMPO), 2.45 (s,
3H, CH3), 2.10-2.05 (overlapped peaks, 4H, CH2-TEMPO), 1.50 (s, 6H, CH3-TEMPO ), support through GTC 31787/23.03.2016.
1.42 (s, 6H, CH3-TEMPO ) ppm. HRMS reduced with TFA (APCI, +, Orbitrap) m/z:
calc. for C25H31N4O3 [M+H]+435.2391; found 435.2386.
Notes and references
N-(1-oxy-2,2,6,6-tetramethylpiperidin-4-yl)-4-(5-(naphthalen-1-yl)-
1,3,4-oxadiazol-2-yl)benzamide 1b. Yellow solid. Yield 60% (29 mg). m.p.
†
Electronic Supplementary Information (ESI) contains
211-214°C (dec.). Rf=0.63 (silica, EtOAc: petroleum ether= 1:2). 1H NMR
experimental procedures and electron paramagnetic spectra,
fluorescence spectra, crystalographic parameters and NMR
spectra
3
reduced with PhNHNH2 (500 MHz, CDCl3): δ= 9.27 (d, 1H, J=8.7 Hz, HAr HAr),
8.28-8.26 (overlapped peaks, 3H,HAr), 8.05 (d, 1H, 3J=8.3 Hz, HAr), 8.00 (d, 2H,
3J=8.3 Hz, HAr), 7.94 (d, 1H, 3J=8.1 Hz, HAr), 7.71 (t, 1H, 3J=7.8 Hz,HAr), 7.62-
7.59 (overlapped peaks, 2H, HAr), 4.68-4.65 (m, 1H, CHTEMPO), 2.50 (m, 2H,
CH2-TEMPO), 2.18-2.15 (m, 2H, CH2-TEMPO), 1.68 (s, 6H, CH3-TEMPO ), 1.54 (s, 6H,
CH3-TEMPO ) ppm. HRMS reduced with TFA (APCI, +, Orbitrap) m/z: calc. for
C28H31N4O3 [M+H]+471.2391;found 471.2381
1
For reviews regarding the use of substitiuted-1,3,4-
oxadiazoles in construction of OLEDs see: a) A. Paun, N.D.
Hadade, C.C. Paraschivescu and M. Matache, J. Mater. Chem.
C, 2016,
Chem. C, 2015,
4
, 8596; b) X. Yang, X. Xu and G. Zhou, J. Mater.
, 913; c) Y. Tao, C. Yang and J. Qin, Chem.
3
4-(5-(anthracen-9-yl)-1,3,4-oxadiazol-2-yl)-N-(1-oxy-2,2,6,6-tetra
methylpiperidin-4-yl)benzamide 1c. Brown solid. Yield 47%, (27 mg). m.p.
254-257°C. Rf=0.53 (silica, EtOAc: petroleum ether= 1:1). 1H NMR reduced
with PhNHNH2 (500 MHz, CDCl3): δ= 8.70 (s, 1H, HAr ), 8.24 (d, 2H, 3J=8.2 Hz,
HAr), 8.10 (d, 2H, 3J=7.6 Hz, HAr), 8.03 (d, 2H, 3J=8.2 Hz, HAr), 7.96 (d, 2H, 3J=7.6
Hz, HAr), 7.56 (overlapped peaks, 4H, HAr), 4.55-4.52 (m, 1H, CHTEMPO), 2.11-
2.04 (m, 4H, CH2-TEMPO), 1.48 (m, 6H, CH3-TEMPO ), 1.40 (m, 6H, CH3-TEMPO ) ppm.
HRMS reduced with TFA (APCI, +, Orbitrap) m/z: calc. for C32H33N4O3 [M+H]+
521.2547; found 521.2535.
Soc. Rev., 2011, 40, 2943; d) G. Hughes and M.R. Bryce, J.
Mater. Chem., 2005, 15, 94; e) A.P. Kulkarni, C.J. Tonzola, A.
Babel and S.A. Jenekhe, Chem. Mater., 2004, 16, 4556.
2
3
For a review see: J. Han, J. Mater. Chem. C, 2013, 1, 7779.
See selected examples for: cations: a) L. Tang, Z. Zheng, Z.
Huang, K. Zhong, Y. Bian, and R. Nandhakumar, RSC Adv.,
2015, 5, 10505. b) C. Köhler and E. Rentschler, Eur. J. Inorg.
Chem., 2016, 1955. anions: c) J. Ma, Z. Li, Y. Zong, Y. Men and
G. Xing, Tetrahedron Lett., 2013, 54, 1348. d) L. Tang, Z.
N-(1-oxy-2,2,6,6-tetramethylpiperidin-4-yl)-4-(5-(pyren-1-yl)-1,3,4-
oxadiazol-2-yl)benzamide 1d. Orange solid. Yield 81% (22 mg). m.p. 249-
251°C (dec.). Rf= 0.78 (silica, EtOAc). 1H NMR reduced with PhNHNH2 (500
MHz, CDCl3): δ= 9.55 (d, 1H, 3J=9.5 Hz, HAr), 8.66 (d, 2H, 3J=8.5 Hz, HAr), 8.31-
8.27 (overlapped peaks, 4H, HAr), 8.23 (t, 2H, 3J=8.5 Hz, HAr), 8.16 (d, 1H,
3J=8.5 Hz, HAr), 8.08-8.05 (overlapped peaks, 2H, HAr), 7.99 (d, 2H, 3J=8.5 Hz,
HAr), 4.59-4.56 (m, 1H, CHTEMPO), 2.15-2.13 (m, 2H, CH2-TEMPO), 2.06-2.04 (m,
2H, CH2-TEMPO), 1.48 (s, 6H, CH3-TEMPO ), 1.44 (s, 6H, CH3-TEMPO ) ppm. HRMS
reduced with TFA (APCI, +, Orbitrap) m/z: calc. for C34H33N4O3 [M+H]+
545.2547; found 545.2535.
Zheng, K. Zhong and Y. Bian, Tetrahedron Lett., 2016, 57
1361.
,
4
5
For selected examples, see: a) Y.-B. Dong, J.-P. Ma, R.-Q.
Huang, M.D. Smith and H.-C. zur Loye, Inorg. Chem., 2003,
42, 294; b) Y.-B. Dong, H.-Y. Wang, J.-P. Ma, D.-Z. Shen and
R.-Q. Huang, Inorg. Chem., 2005, 44, 4679; c) C. Anghel, M.
Matache, C.C. Paraschivescu, A. M. Madalan and M Andruh,
Inorg. Chem. Commun., 2017, 76, 22.
a) Z. Wang, H. Zhang, B.J. Killian, F. Jabeen, G.G. Pillai, H.M.
Berman, M. Mathelier, A.J. Sibble, J. Yeung, W. Zhou, P.J.
Steel, C.D. Hall and A.R. Katritzky, Eur. J. Org. Chem., 2015,
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins